82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
GE HealthCare Technologies price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
GE HealthCare Technologies's P/S ratio is 1.81: its market cap of 37.25B USD over revenue of 20.61B USD in the last twelve months.
- Today
- 1.81
- Average, 5 years
- 1.78
- Low, 5 years
- 1.36
- High, 5 years
- 2.20
P/S ratio = market cap ÷ revenue (last 12 months) = 37.25B ÷ 20.61B = 1.81
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 1.81 | 37.25B | 20.61B | |
| FY2025 | 31 Dec 2025 | 1.82 | 37.44B | 20.63B |
| FY2024 | 31 Dec 2024 | 1.81 | 35.65B | 19.67B |
| FY2023 | 31 Dec 2023 | 1.80 | 35.18B | 19.55B |
| FY2022 | 31 Dec 2022 | 1.44 | 26.50B | 18.34B |
| FY2021 | 31 Dec 2021 | 1.55 | 27.28B | 17.59B |
| FY2020 | 31 Dec 2020 | 1.59 | 27.28B | 17.16B |
| FY2019 | 31 Dec 2019 | 1.64 | 27.28B | 16.63B |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.43 | 29.55B | 20.61B |
| Q2 FY2026 | 30 Jun 2026 | 1.43 | 29.00B | 20.24B |
| Q1 FY2026 | 31 Mar 2026 | 1.63 | 32.46B | 19.95B |
| Q4 FY2025 | 31 Dec 2025 | 1.91 | 37.44B | 19.60B |
| Q3 FY2025 | 30 Sept 2025 | 1.69 | 34.25B | 20.25B |
| Q2 FY2025 | 30 Jun 2025 | 1.70 | 33.85B | 19.97B |
| Q1 FY2025 | 31 Mar 2025 | 1.86 | 36.88B | 19.80B |
| Q4 FY2024 | 31 Dec 2024 | 1.82 | 35.73B | 19.67B |
| Q3 FY2024 | 30 Sept 2024 | 2.19 | 42.89B | 19.56B |
| Q2 FY2024 | 30 Jun 2024 | 1.79 | 34.85B | 19.52B |
| Q1 FY2024 | 31 Mar 2024 | 2.09 | 40.83B | 19.50B |
| Q4 FY2023 | 31 Dec 2023 | 1.80 | 35.18B | 19.55B |
| Q3 FY2023 | 30 Sept 2023 | 1.61 | 30.96B | 19.28B |
| Q2 FY2023 | 30 Jun 2023 | 1.94 | 36.96B | 19.04B |
| Q1 FY2023 | 31 Mar 2023 | 1.99 | 37.24B | 18.71B |
| Q4 FY2022 | 31 Dec 2022 | 1.44 | 26.50B | 18.34B |
| Q3 FY2022 | 30 Sept 2022 | 1.51 | 27.24B | 17.99B |
| Q2 FY2022 | 30 Jun 2022 | 1.54 | 27.24B | 17.72B |
| Q1 FY2022 | 31 Mar 2022 | 1.55 | 27.24B | 17.58B |
| Q4 FY2021 | 31 Dec 2021 | 1.55 | 27.28B | 17.59B |
| Q3 FY2021 | 30 Sept 2021 | — | 27.28B | — |
| Q2 FY2021 | 30 Jun 2021 | — | 27.28B | — |
| Q1 FY2021 | 31 Mar 2021 | — | 27.28B | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about GE HealthCare Technologies's P/S ratio
Source: Financial Modeling Prep
